Back to search
Agitation in Patients With Dementia of the Alzheimer's Type
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Agitation in Patients With Dementia of the Alzheimer's Type trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Agitation in Patients With Dementia of the Alzheimer's Type trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
To evaluate the efficacy and safety of ONO-2020 in patients with agitation associated with Alzheimer's Disease dementia in Japan.
This is a multicenter, randomized, double-blind, placebo-controlled, flexible-dose study of the efficacy, safety, and tolerability of ITI-1284 in patients with…
This is a randomized, double-blinded, placebo-controlled, crossover trial that aims to 1) determine the efficacy of THC-free cannabidiol (CBD oil) in reducing t…
The primary objective of this open-label extension trial was to evaluate the long-term safety of AXS-05 for the treatment of Alzheimer's disease agitation in su…
This study tests a medication called dronabinol in people with Alzheimer's disease. First, participants go through up to 4 weeks of screening. Then, over 2 week…